New, rare mechanism for ALL to relapse after CAR T cell therapy
A single leukemia cell, unknowingly engineered with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient, was able to reproduce and cause a deadly recurrence of B-cell acute lymphoblastic leukemia (ALL).
from Latest Science News -- ScienceDaily https://ift.tt/2P40eEy
from Latest Science News -- ScienceDaily https://ift.tt/2P40eEy
Comments
Post a Comment